HK2 and pancreatic adenocarcinoma: In conclusion, a novel glycolysis-related LINC02432/hsa-miR-98–5p/HK2 ceRNA network targeting PAAD patients was constructed and its functions were analyzed, which may establish new insights for clinical decision making and precision medicine.